PyroGenesis Announces Upsize of Bought Deal LIFE Offering to $3.7 Million

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES MONTREAL, May 20, 2026 (GLOBE NEWSWIRE) -- PyroGenesis Inc. (“PyroGenesis” or the “Company”) (TSX: PYR) (OTCQX: PYRGF) (FRA: 8PY1), a leader in ultra-high temperature processes and engineering innovation, and a plasma-based technology provider to heavy industry & defense, announces today that due to strong investor demand, it has entered into an amendment agreement with Research Capital Corporation (“RCC”), as the sole underwriter and sole bookrunner (the “Underwriter”), to increase the size of its previously announced “bought deal” offering, pursuant to which the Underwriter has agreed to purchase, on a “bought deal” basis pursuant to the Listed Issuer Financing Exemption (“LIFE”), 10,882,500 units of the Company (the “Units”) for aggregate gross proceeds to the Company of $3,700,050 (the “Offering”) at a price per Unit of $0.34 (the “Offering Price”). Each Unit will consist of one common share of the Company (a “Common Share”) and one Common Share purchase warrant of the Company (a “Warrant”).